DR.MAX secures contract for Antineoplastic and immunomodulating agents - framework agreement for the supply of medicines from the group; "ANTINEOPLASICS AND IMMUNOMODULATORS" - SACITUZUMAB GOVITECAN POWDER PT CONC PT SOL PERF 200 MG

Romania, Oct. 7 -- Romania based DR.MAX has secured contract from Operator SEAP for Antineoplastic and immunomodulating agents - framework agreement for the supply of medicines from the group; "ANTINEOPLASICS AND IMMUNOMODULATORS" - SACITUZUMAB GOVITECAN POWDER PT CONC PT SOL PERF 200 MG. The value of the contract is worth 209624.85 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....